AI Pulse: Reshaping Public Health ๐Ÿš€๐Ÿฅ

July 20, 2026 |

AI

๐ŸŽง Audio Summaries
English flag
French flag
German flag
Japanese flag
Korean flag
Mandarin flag
Spanish flag
๐Ÿ›’ Shop on Amazon

๐Ÿง Quick Intel


  • The Public Health Use Case and Learning Scaling Engine (PULSE) program will involve 10 US jurisdictions, supported by OpenAI and Anthropic, to test generative AI tools.
  • OpenAI and Anthropic are donating 10 enterprise licenses with capacity for up to 2,000 public health practitioners to participate in the trials.
  • Five public health use cases are being explored, including biosurveillance, SDoH mapping, community feedback analysis, multilingual translation, and clinical data retrieval.
  • NISTโ€™s AI Risk Management Framework will be used to evaluate the AI systems, considering use, environment, affected parties, and potential consequences.
  • The PULSE deployments will be configured without defined retention periods, access controls, or data-storage requirements, aiming to facilitate initial evaluation.
  • Nearly 40% of local health departments are not currently using AI, according to data from the National Association of County and City Health Officials, indicating a potential need for AI solutions.
  • CHAI anticipates releasing playbooks based on the pilots in 2027, intended for wider use by other public health agencies, following work on governance standards with the Joint Commission.
  • ๐Ÿ“Summary


    Across the United States, public health departments are preparing to test generative AI tools through a new initiative called PULSE. The Coalition for Health AI, alongside OpenAI, Anthropic, and Accenture, is spearheading this program, providing 10 state and local jurisdictions with enterprise licenses for AI products like ChatGPT Enterprise. Accenture will assist with implementation and playbook development, focusing on five key use cases including biosurveillance and social determinants of health analysis. While OpenAI and Anthropic state their commercial products wonโ€™t be used for training, the program emphasizes governance and responsible use, aligning with NISTโ€™s AI Risk Management Framework. The pilots, slated to begin in autumn 2026, aim to provide practical experience for public health agencies, particularly given the historical underinvestment in technology within the sector. CHAI anticipates releasing guidance based on the findings in 2027, intending to inform wider adoption and ultimately address the challenge of doing more with less, with careful consideration for privacy and operational safeguards.

    ๐Ÿ’กInsights

    โ–ผ


    CHAPTER 1: AI Deployment Initiative Launch
    OpenAI, Anthropic, and Accenture are partnering with the Coalition for Health AI to implement the Public Health Use Case and Learning Scaling Engine (PULSE) program. This initiative will involve 10 state, local, tribal, or territorial jurisdictions, providing public health practitioners with access to enterprise AI products. Dr. David Lakey emphasizes the importance of trust, governance, and execution in the success of technological transformations. Accenture will manage onboarding and playbook development, aiming to facilitate a structured evaluation process for generative AI tools.

    CHAPTER 2: Program Scope and Use Cases
    The PULSE program centers around five key public health use cases: biosurveillance and drug-wave prediction, social determinants of health (SDoH) mapping, operational and efficiency improvements, community-feedback analysis, and automated clinical-data retrieval with a FHIR query engine. NISTโ€™s AI Risk Management Framework provides a foundation for evaluating these systems, focusing on intended use, operating environment, affected parties, and potential consequences. The programโ€™s goals include facilitating healthcare information electronically between compatible systems.

    CHAPTER 3: Data Governance and Privacy Considerations
    The implementation of PULSE necessitates careful consideration of data governance and privacy. The US Department of Health and Human Services (HHS) regulations, particularly HIPAA, apply to organizations handling electronic protected health information (ePHI). However, the extent of HIPAAโ€™s applicability within the PULSE program is nuanced and dependent on the specific agency, data involved, and function being performed. OpenAI and Anthropic both state that their business servicesโ€™ inputs and outputs are not used for model training by default, requiring careful monitoring and controls.

    CHAPTER 4: Operational Details and Pilot Timeline
    The PULSE initiative is scheduled to commence in autumn 2026, with CHAI anticipating the release of playbooks in 2027 for wider adoption. The program's focus is on providing enterprise licenses, onboarding support, and peer communities to participating jurisdictions. Crucially, the announcement lacks specifics regarding retention periods, access controls, audit arrangements, data-storage requirements, or rules governing the submission of protected health information. The governance and evaluation criteria for the pilot programs remain undefined.

    CHAPTER 5: Strategic Objectives and Future Development
    The Coalition for Health AIโ€™s broader work encompasses the development of governance standards for healthcare AI, including guidance across eight key areas through workshops and working groups. The organization has already begun publishing playbooks on organizational AI policies, governance structures, and internal resources, aligning with its voluntary Responsible Use of AI in Healthcare certification. The PULSE program represents a key step in this ongoing effort, aiming to convert findings from 10 jurisdictions into guidance for broader use, while acknowledging the diverse needs of participating agencies.